The primary objective of the Biostatistics and Bioinformatics Shared Facility (BBSF) is to provide centralized statistical services and collaborative research support for the research projects of the Cancer Center. To accomplish this, the BBSF has the following specific aims: 1) coordinate and manage statistical activities in the Cancer Center, ensuring that investigators have ready access to statistical consultation and support;2) provide data analysis for Cancer Center projects using contemporary statistical methodologies;3) provide statistical consultation on study design and research proposal development including pilot projects;4) participate in teaching and training activities of the Cancer Center;5) provide data management for the Clinical Protocol and Data Management (CPDM) Shared Facility including integration with OnCore;6) develop and manage SPORE databases;7) provide support for analysis of genetic data from UAB's Microarray Shared Facility and Hudson Alpha;8) maintain a data and information computing system integrated with the Cancer Center's Data Sharing Plan;9) develop methodologies for novel experimental designs and analyses that will enhance the BBSF's technical capabilities in providing collaborative research support. In addition to supporting the conventional needs of researchers, the BBSF has responded to the increasing role of multidimensional data analyses in mechanistic and functional studies using 'omic' technologies. The BBSF currently is composed of a team of faculty members and support staff from the Division of Preventive Medicine in the School of Medicine, and additional adjunct faculty from the Department of Biostatistics in the School of Public Health. By organizing as the BBSF they provide the Cancer Center investigators easy access to well-established and comprehensive biostatistical support in a very costeffective manner. The BBSF also has several integrative functions, as noted by the support for the SPOREfunded projects and the management of OnCore? for the Clinical Protocol and Data Management (CPDM) Shared Facility. Importantly, the BBSF also serves as a continuous point of contact with our partners, Morehouse School of Medicine and Tuskegee University, by providing regular support and training in research design as part of the Cancer Partnership. The success of the facility is evident through the high volume of publications for which the BBSF provided key support in research design and statistical analyses.
In order to provide the most valid results, research studies should begin with good experimental design, be well managed, and end with appropriate analysis for the data. The BBSF serves as the focal point from which cancer center investigators draw the necessary statistical expertise for the design, management and analysis of cancer research projects. Through this work, the BBSF helps the CCC to achieve its goals to improve cancer prevention and outcomes.
|Carson, Tiffany L; Hardy, Claudia M; Greene, Eva et al. (2014) Considerations for bio-specimen collection among black women residing in the rural Deep South participating in a cancer prevention study. J Community Genet 5:257-63|
|Fauci, Janelle M; Sabbatino, Francesco; Wang, Yangyang et al. (2014) Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96. Gynecol Oncol 132:203-10|
|Devine, D J; Rostas, J W; Metge, B J et al. (2014) Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-*/SMAD signaling. Oncogene 33:2620-8|
|Kim, Hyunki; Rigell, Christopher J; Zhai, Guihua et al. (2014) Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers. Mol Imaging Biol 16:85-94|
|Saini, Reshu; Hoyt, Kenneth (2014) Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis. Imaging Med 6:41-52|
|Sonpavde, Guru; Willey, Christopher D; Sudarshan, Sunil (2014) Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma. Expert Opin Investig Drugs 23:305-15|
|Shim, Eun-Hee; Livi, Carolina B; Rakheja, Dinesh et al. (2014) L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov 4:1290-8|
|Gan, Yujun; Buckels, Ashiya; Liu, Ying et al. (2014) Human GH receptor-IGF-1 receptor interaction: implications for GH signaling. Mol Endocrinol 28:1841-54|
|Johnson, David H; Wilson, W William; DeLucas, Lawrence J (2014) Protein solubilization: a novel approach. J Chromatogr B Analyt Technol Biomed Life Sci 971:99-106|
|Ramos, Theresa N; Bullard, Daniel C; Barnum, Scott R (2014) ICAM-1: isoforms and phenotypes. J Immunol 192:4469-74|
Showing the most recent 10 out of 364 publications